- Home
- WFG vs MMSI Comparison
WFG vs MMSI Comparison
Compare WFG & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- MMSI
- Stock Information
- Founded
- WFG 1955
- MMSI 1987
- Country
- WFG Canada
- MMSI United States
- Employees
- WFG N/A
- MMSI N/A
- Industry
- WFG
- MMSI Medical/Dental Instruments
- Sector
- WFG
- MMSI Health Care
- Exchange
- WFG Nasdaq
- MMSI Nasdaq
- Market Cap
- WFG 6.0B
- MMSI 5.5B
- IPO Year
- WFG N/A
- MMSI 1990
- Fundamental
- Price
- WFG $72.77
- MMSI $92.98
- Analyst Decision
- WFG Buy
- MMSI Buy
- Analyst Count
- WFG 3
- MMSI 9
- Target Price
- WFG $105.00
- MMSI $109.11
- AVG Volume (30 Days)
- WFG 221.2K
- MMSI 551.4K
- Earning Date
- WFG 07-23-2025
- MMSI 07-31-2025
- Dividend Yield
- WFG 1.75%
- MMSI N/A
- EPS Growth
- WFG N/A
- MMSI 17.19
- EPS
- WFG N/A
- MMSI 2.04
- Revenue
- WFG $6,006,000,000.00
- MMSI $1,388,357,000.00
- Revenue This Year
- WFG $1.36
- MMSI $11.68
- Revenue Next Year
- WFG $8.10
- MMSI $6.27
- P/E Ratio
- WFG $2,907.58
- MMSI $45.86
- Revenue Growth
- WFG N/A
- MMSI 8.19
- 52 Week Low
- WFG $69.48
- MMSI $82.35
- 52 Week High
- WFG $102.40
- MMSI $111.45
- Technical
- Relative Strength Index (RSI)
- WFG 44.23
- MMSI 43.49
- Support Level
- WFG $72.92
- MMSI $91.12
- Resistance Level
- WFG $75.08
- MMSI $93.64
- Average True Range (ATR)
- WFG 1.75
- MMSI 1.59
- MACD
- WFG -0.18
- MMSI -0.08
- Stochastic Oscillator
- WFG 9.23
- MMSI 32.68
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board producers in the world.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.